Empirical Financial Services LLC d.b.a. Empirical Wealth Management Purchases Shares of 14,601 Smith & Nephew SNATS, Inc. $SNN

Empirical Financial Services LLC d.b.a. Empirical Wealth Management acquired a new position in Smith & Nephew SNATS, Inc. (NYSE:SNNFree Report) during the third quarter, HoldingsChannel reports. The institutional investor acquired 14,601 shares of the medical equipment provider’s stock, valued at approximately $530,000.

Several other hedge funds have also recently made changes to their positions in SNN. GAMMA Investing LLC lifted its stake in Smith & Nephew SNATS by 11.7% in the third quarter. GAMMA Investing LLC now owns 3,837 shares of the medical equipment provider’s stock worth $139,000 after acquiring an additional 401 shares during the period. Versant Capital Management Inc raised its holdings in Smith & Nephew SNATS by 5.0% in the 3rd quarter. Versant Capital Management Inc now owns 8,912 shares of the medical equipment provider’s stock worth $323,000 after purchasing an additional 423 shares in the last quarter. Inspire Investing LLC raised its holdings in Smith & Nephew SNATS by 7.1% in the 3rd quarter. Inspire Investing LLC now owns 7,789 shares of the medical equipment provider’s stock worth $283,000 after purchasing an additional 516 shares in the last quarter. Cary Street Partners Financial LLC lifted its position in shares of Smith & Nephew SNATS by 3.8% in the 2nd quarter. Cary Street Partners Financial LLC now owns 20,005 shares of the medical equipment provider’s stock worth $613,000 after purchasing an additional 725 shares during the period. Finally, MAI Capital Management boosted its stake in shares of Smith & Nephew SNATS by 24.0% during the 2nd quarter. MAI Capital Management now owns 4,371 shares of the medical equipment provider’s stock valued at $134,000 after purchasing an additional 846 shares in the last quarter. 25.64% of the stock is owned by hedge funds and other institutional investors.

Smith & Nephew SNATS Stock Up 0.1%

Shares of SNN opened at $36.17 on Tuesday. The company has a debt-to-equity ratio of 0.60, a current ratio of 3.00 and a quick ratio of 1.40. The business’s 50 day moving average price is $33.85 and its 200-day moving average price is $34.94. Smith & Nephew SNATS, Inc. has a 52 week low of $23.91 and a 52 week high of $38.79.

Wall Street Analyst Weigh In

SNN has been the subject of a number of research reports. Kepler Capital Markets raised shares of Smith & Nephew SNATS to a “strong-buy” rating in a research note on Monday, November 17th. Royal Bank Of Canada lowered Smith & Nephew SNATS from an “outperform” rating to a “sector perform” rating in a research report on Monday, December 15th. Weiss Ratings restated a “hold (c+)” rating on shares of Smith & Nephew SNATS in a research note on Wednesday, January 21st. Wall Street Zen lowered Smith & Nephew SNATS from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Finally, Canaccord Genuity Group decreased their price objective on Smith & Nephew SNATS from $36.00 to $34.00 and set a “hold” rating for the company in a report on Tuesday, November 11th. One analyst has rated the stock with a Strong Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Smith & Nephew SNATS has a consensus rating of “Hold” and an average price target of $35.75.

Read Our Latest Stock Analysis on SNN

About Smith & Nephew SNATS

(Free Report)

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.

See Also

Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew SNATS, Inc. (NYSE:SNNFree Report).

Institutional Ownership by Quarter for Smith & Nephew SNATS (NYSE:SNN)

Receive News & Ratings for Smith & Nephew SNATS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS and related companies with MarketBeat.com's FREE daily email newsletter.